lutein has been researched along with Geographic Atrophy in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (78.57) | 24.3611 |
2020's | 3 (21.43) | 2.80 |
Authors | Studies |
---|---|
Drakon, AK; Korchazhkina, NB; Kurguzova, AG; Sheludchenko, VM | 1 |
Evans, JR; Lawrenson, JG | 2 |
Agrón, E; Chew, EY; Cukras, CA; Domalpally, A; Hwang, CK; Keenan, TDL; Wong, WT | 1 |
Agrón, E; Chew, EY; Clemons, TE; Danis, RG; Domalpally, A; Ferris, FL; Keenan, TD; Klein, ML; Ratnapriya, R; Rosenfeld, PJ; Sadda, S; Swaroop, A; van Asten, F; Wong, WT | 1 |
Dawczynski, J; Hammer, M; Jentsch, S; Lang, GE; Schweitzer, D; Strobel, J | 1 |
Beatty, S; Chakravarthy, U; Muldrew, KA; Nolan, JM; Stevenson, MR; Woodside, J | 1 |
Agrón, E; Antoszyk, AN; Bernstein, PS; Blodi, BA; Bressler, SB; Chandra, SR; Chew, EY; Clemons, TE; Danis, RP; Domalpally, A; Elman, MJ; Ferris, FL; Fish, GE; Friberg, T; Hubbard, GB; Klein, ML; Orth, D; Rosenfeld, PJ; Ruby, AJ; Sangiovanni, JP; Sperduto, RD; Toth, CA; Wong, WT | 1 |
Agrón, E; Al-Holou, SN; Chew, EY; Clemons, TE; Cukras, C; Ferris, FL; Tucker, WR | 1 |
Garhöfer, G; Michels, S | 1 |
Batioglu, F; Demirel, S; Gedik-Oguz, Y; Ozmert, E | 1 |
Chew, EY; Clemons, TE; Cukras, CA; Danis, RP; Domalpally, A; Friberg, TR; Sadda, SR; Toth, CA | 1 |
Kontadakis, G; Makridaki, M; Moschandreas, J; Plainis, S; Tsika, C; Tsilimbaris, MK | 1 |
Biswas, S; Gupta, A; Raman, R | 1 |
3 review(s) available for lutein and Geographic Atrophy
Article | Year |
---|---|
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Topics: Antioxidants; beta Carotene; Dietary Supplements; Female; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Male; Malnutrition; Minerals; Vitamin A; Vitamin K; Vitamins; Zeaxanthins; Zinc | 2023 |
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Topics: Aged; Antioxidants; Dietary Supplements; Disease Progression; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Minerals; Quality of Life; Randomized Controlled Trials as Topic; Vitamin E; Vitamins; Zeaxanthins; Zinc | 2017 |
Nonneovascular Age-Related Macular Degeneration.
Topics: Antioxidants; Fatty Acids, Omega-3; Geographic Atrophy; Humans; Lutein; Zeaxanthins | 2016 |
7 trial(s) available for lutein and Geographic Atrophy
Article | Year |
---|---|
Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-Related Macular Degeneration: AREDS2 Report 24.
Topics: Aged; Aged, 80 and over; Diagnostic Imaging; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Follow-Up Studies; Geographic Atrophy; Humans; Lutein; Macula Lutea; Male; Middle Aged; Prospective Studies; Treatment Outcome; Wet Macular Degeneration; Zeaxanthins | 2021 |
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Topics: Aged; Aged, 80 and over; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photography; Prospective Studies; Visual Acuity; Zeaxanthins | 2018 |
Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.
Topics: Aged; Antioxidants; Ascorbic Acid; Dietary Supplements; Double-Blind Method; Drug Combinations; Fatty Acids, Omega-3; Female; Follow-Up Studies; Geographic Atrophy; Humans; Lutein; Male; Middle Aged; Prospective Studies; Retinal Pigments; Visual Acuity; Vitamin E; Xanthophylls; Zeaxanthins; Zinc Compounds | 2013 |
Visual outcome after antioxidant supplementation.
Topics: Administration, Oral; Antioxidants; Ascorbic Acid; Double-Blind Method; Drug Therapy, Combination; Geographic Atrophy; Gluconates; Humans; Lutein; Middle Aged; Trace Elements; Treatment Outcome; Visual Acuity; Vitamin E; Wet Macular Degeneration; Xanthophylls; Zeaxanthins; Zinc Oxide | 2013 |
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
Topics: Administration, Oral; Aged; Aged, 80 and over; beta Carotene; Diet; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Geographic Atrophy; Humans; Lutein; Male; Middle Aged; Retinal Drusen; Trace Elements; Treatment Outcome; Visual Acuity; Vitamins; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2014 |
The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Dietary Supplements; Disease Progression; Fatty Acids, Omega-3; Female; Follow-Up Studies; Geographic Atrophy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lutein; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Visual Acuity; Wet Macular Degeneration; Zeaxanthins | 2015 |
Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Grou
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Lutein; Male; Middle Aged; Optical Imaging; Prospective Studies; Retina; Retinal Drusen; Retinal Pigment Epithelium; Tomography, Optical Coherence; Wet Macular Degeneration; Zeaxanthins | 2017 |
4 other study(ies) available for lutein and Geographic Atrophy
Article | Year |
---|---|
[Pharmacological and physiotherapeutic methods of treating non-exudative age-related macular degeneration].
Topics: Disease Progression; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Retinal Drusen; Zeaxanthins | 2021 |
A Color Perimetric Test to Evaluate Macular Pigment Density in Age-Related Macular Degeneration.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Geographic Atrophy; Healthy Volunteers; Humans; Lutein; Macula Lutea; Macular Pigment; Male; Observer Variation; Reproducibility of Results; Visual Field Tests; Zeaxanthins | 2016 |
Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Geographic Atrophy; Humans; Intraocular Pressure; Lutein; Male; Middle Aged; Photometry; Retinal Pigments; Visual Acuity; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2011 |
Re: Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Topics: Female; Geographic Atrophy; Humans; Lutein; Male; Retinal Pigments; Wet Macular Degeneration; Xanthophylls | 2012 |